Integration of Equipoise into Eligibility Criteria in the STARRT-AKI Trial
Am J Respir Crit Care Med
.
2021 Jul 15;204(2):234-237.
doi: 10.1164/rccm.202009-3425LE.
Authors
Ron Wald
1
,
Sean M Bagshaw
2
;
STARRT-AKI Investigators
Collaborators
STARRT-AKI Investigators
:
Sean M Bagshaw
,
Ron Wald
,
Neill K J Adhikari
,
Rinaldo Bellomo
,
Didier Dreyfuss
,
Bin Du
,
Martin P Gallagher
,
Stéphane Gaudry
,
Eric A Hoste
,
François Lamontagne
,
Michael Joannidis
,
Kathleen D Liu
,
Daniel F McAuley
,
Shay P McGuinness
,
Alistair D Nichol
,
Marlies Ostermann
,
Paul M Palevsky
,
Haibo Qiu
,
Ville Pettilä
,
Antoine G Schneider
,
Orla M Smith
,
Suvi Vaara
,
Matthew Weir
Affiliations
1
St. Michael's Hospital Toronto, Ontario, Canada.
2
University of Alberta and Alberta Health Services Edmonton, Alberta, Canada.
PMID:
33939598
DOI:
10.1164/rccm.202009-3425LE
No abstract available
Publication types
Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Acute Kidney Injury*
Humans
Patient Selection
Therapeutic Equipoise
Grants and funding
MOP142296/CIHR/Canada
389635/CIHR/Canada
IPR 139081/CIHR/Canada